High Court

Advanced Cell Diagnostics v Molecular Instruments (ongoing) – Patent infringement and revocation action concerning fluorescence in situ hybridisation (FISH) technology.

Pfizer v GSK (ongoing) – Patent infringement and revocation action concerning a vaccine for respiratory syncytial virus.

Accord v Astellas (ongoing) – Patent and SPC infringement and revocation action concerning the small molecule anti-androgen enzalutamide in the treatment of prostate cancer.

AutoStore Technology v Ocado Group & ors [2023] EWHC 716 (Pat) – Patent infringement and entitlement actions concerning automated robotic storage and retrieval technology, giving rise to novel conflicts of law issues under Rome II, the public availability of prior disclosures made in terms of confidence, and infringement by equivalence.

R2 v Intel – Patent action concerning Intel’s processor chips which incorporate fully integrated voltage regulators. Acted in a successful expedition application to a September trial.

Ericsson v Apple – Multi-jurisdictional telecoms case concerning 4G and 5G systems and FRAND issues.

Sandoz v Biogen (ongoing) – Patent action concerning a biosimilar antibody, natalizumab, for treatment of relapse remitting multiple sclerosis. Acted in successful applications to expedite the trial and resist a stay of UK proceedings pending parallel EPO opposition.

Pfizer v Amgen  – Patent revocation action relating to bispecific BCMAxCD3 antibodies for the treatment of multiple myeloma. Acted in a successful application to list the trial prior to the CMC.

Sandoz, Teva v Bristol-Myers Squibb [2022] EWHC 822 (Pat) – Pharmaceutical patents action concerning the blockbuster anticoagulant apixaban giving rise to issues of plausibility and the sufficiency of product per se claims.

Dr Reddy’s, Actavis, NHS England & ors v Warner-Lambert, Pfizer [2021] EWHC 2182 (Ch) (ongoing) – High-profile damages inquiry emanating from long-running pregabalin litigation.

Advanced Bionics v Med-El [2021] EWHC 2415 (Pat) – A successful expedition application for cochlear implant patent litigation proceeding on the Shorter Trials Scheme.

Edwards Lifesciences Corp v Meril GmbH [2021] EWHC 761 (Pat) – Prosthetic aortic valve medical device litigation.

Akebia v Fibrogen, Astellas [2020] EWHC 866 (Pat) – Multi-patent pharmaceutical action concerning the treatment of anaemia with small molecule inhibitors raising issues of plausibility and construction of purpose-limited claims.

IPEC

Kohler Mira v Triton (ongoing) – Patent infringement dispute in IPEC concerning electrical showers.

Don-Bur v Fluid Power – Mechanical patent dispute in IPEC concerning trailer design.

Trade marks

Admiral v Admiral Markets (ongoing) – Trade mark and contract dispute concerning the Admiral brand.

Prime Online Ltd v Amazon Technologies, Inc (ongoing) ­– Dispute concerning the trade name PRIME GAMING, with parallel proceedings in the IPO involving the bad faith ground.

Virgin v Heineken – Trade mark dispute concerning the use of VIRGIN in relation to low- or no-alcohol beer.

William Grant v Lidl [2021] CSOH 55 – Assisted in Scottish litigation concerning the Hendrick’s gin brand.

Rolex v Titan Black & ors (IL-2021-000096) – Trade mark infringement claim concerning customised Rolex watches and raising issues of exhaustion of rights.

Millington v Wolf 1834 Ltd & or (IP-2022-000007) – Trade mark infringement dispute concerning watch winders in IPEC.

Medical devices company v Medical devices company – Trade mark and passing off dispute relating to COVID-19 medical diagnostic tests.

Medical devices company v Medical devices company – Comparative advertising trade mark dispute concerning sutures.

CORNERSTONE (O/096/22) – Appeal to the Appointed Person for this trade mark application relating to financial and other services.

Various ongoing oppositions before the UKIPO

Other intellectual property rights

Songtradr v Ditto, Bluebox, Block8 – Dispute concerning copyright and confidential information in blockchain software relating to music licensing, including issues of relative confidentiality and springboard injunctive relief.

• 2019-2020: 12-month pupillage at Three New Square to Miles Copeland, Jeremy Heald, Joe Delaney, Stuart Baran and Geoff Pritchard
• 2017-2018: BPTC at BPP Birmingham: Outstanding; 1st in cohort
• 2016-2017: GDL at BPP Birmingham: Distinction
• 2012-2016: MChem Chemistry at Lincoln College, Oxford: 1st
  class. Part-II thesis in soft chemistry of solid-state crystalline compounds from the cerium oxychalcogenide series

Lord Denning and Lord Brougham scholarships, Hardwicke award, from Lincoln’s Inn

College Scholar, L H Martin prize, and Sidgwick Exhibition from Lincoln College, Oxford

In 2018-2019, Thomas worked at Carpmaels & Ransford LLP. He was involved with a pharmaceutical patents matter relating to anti-CGRP antibodies for the treatment of migraine.

Thomas Lunt’s privacy notice can be found here.